NEU 0.35% $20.17 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-145

  1. 12,999 Posts.
    lightbulb Created with Sketch. 774
    Anydaynow: To me your post does make a lot of sense. Time will tell and I believe that NEU management can be trusted to work in the best interest of all NEU shareholders.

    wasa
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.